Amelioration of Extra-articular Effects Associated with Rheumatoid Arthritis Using Anti-arthritic Herbal Formulations

Main Article Content

Kemzi N. Elechi-Amadi
Ojoye N. Briggs
Boma H. Opusunju
Ebirien-Agana S. Bartimaeus
Edna O. Nwachuku

Abstract

Aim: This study investigated the ability of some herbal formulations to ameliorate extra-articular effects of some herbal formulations used in the management of rheumatoid arthritis in Nigeria.

Methodology: Forty-nine (49) female albino Wistar rats were used for this study. They were divided into seven groups: A, B, C, D, E, F and G of seven rats each, with Group A serving as negative control while Group B was a positive control. Groups B, C, D, E, F and G were induced with rheumatoid arthritis by injecting 0.1 ml of Complete Freund's Adjuvant into the right hind paw of each rat. The rats were treated with the standard drug and herbal formulations respectively for 28 days as follows: Group C (treated with a standard drug, Celebrex), Group D (treated with the herbal drug, Jointeez), Group E (treated with a herbal drug, Arthropower), Group F (treated with combination therapy of Jointeez and Celebrex) and Group G (treated with combination therapy of Arthropower and Celebrex). At the end of the 28-day treatment period, the rats were anaesthetized with chloroform and sacrificed through puncture of the jugular vein. Five millilitres (5 ml) of blood samples were put into plain bottles for the analysis of biochemical parameters and 3 ml into K3EDTA bottles for haematological analysis. The lipid parameters were analysed using Mindray autoanalyzer while haematological parameters were determined using Sysmex haematology auto analyzer.

Results: Total cholesterol (p<0.001), HDL (p=0.005) and LDL (p=0.004) were significantly reduced in the treated rats compared to the positive control group. Conversely, Packed Cell Volume (p<0.001) and Haemoglobin levels (p<0.001) were significantly reduced in the positive control rats compared to the treated rats. However, Total WBC count was significantly higher in the positive control rats than in the treated rats (p=0.001). The combination therapies used in this study did not offer a significantly different therapeutic advantage over the monotherapies used. The herbal formulations gave therapeutic effects on the extra-articular effects similar to that obtained from the orthodox drug used in this study. 

Conclusion: The herbal formulations can be used as alternative regimens for rheumatoid arthritis. It is recommended that herbal formulations be considered for integration into our healthcare system for the management of rheumatoid arthritis.

Keywords:
Anti-arthritic, herbal formulation, complete Freund’s adjuvant, rheumatoid arthritis, Nigeria.

Article Details

How to Cite
Elechi-Amadi, K. N., Briggs, O. N., Opusunju, B. H., Bartimaeus, E.-A. S., & Nwachuku, E. O. (2020). Amelioration of Extra-articular Effects Associated with Rheumatoid Arthritis Using Anti-arthritic Herbal Formulations. Journal of Complementary and Alternative Medical Research, 9(2), 11-20. https://doi.org/10.9734/jocamr/2020/v9i230137
Section
Original Research Article

References

Choy E. Understanding the dynamics: Pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology. 2012;51(5):3-11.

Koop SM, Ten Klooster PM, Vonkeman HE, Steunebrink LM, van de Laar MA. Neuropathic-like pain features and cross-sectional associations in rheumatoid arthritis. Arthritis research & therapy. 2015;17(1):237-247.

McInnes IB, Schett G. Pathogensis of rheumatoid arthritis. New England Journal of Medicine. 2011;365:2205-2219.

Smolen JS, Aletaha D, McInnes IB. Rheumatoid Arthritis. Lancet. 2016;388:2023-2038.

Das S, Padhan P. An overview of the extra-articular involvement in rheumatoid arthritis and its management. Journal of Pharmacology & Pharmacotherapeutics. 2017;8(3):81-86.

Madjid M, Willerson JT. Inflammatory markers in coronary heart disease. British Medical Bulletin. 2011;100:23-38.

Crowson CS, Liao KP, Davis JM, Solomon DH, Matterson EL, Knutson KL, Hlatky MA, Gabriel SE. Rheumatoid arthritis and cardiovascular disease. American Heart Journal. 2013;166(4): 622-628.

Giles JT, Post WS, Blumenthal RS, Polak J, Petri M, Gelber AC, Szkle M, Bathom JM. Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis. Arthritis and Rheumatism. 2011;63(11):3216-3225.

Grassia G, Maddaluno M, Musili C, de Stefano D, Carnuccio R, di Lauro MV. The I(kappa)B kinase inhibitor nuclear Factor-kappa B essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation. Arteriosclerosis, Thrombosis and Vascular Biology. 2010;30:2458-2466.

Kalliolias GD, Washkiu LB. TNF Biology, Pathogenic mechanisms and emerging therapeutic strategies. Nature Review Rheumatology. 2016;12:49-62.

Hashizume R, Mihara M. Atherogenic effects of TNF-α and IL-6 via upregulation of scavenger receptors. Cytokines. 2012;58:424-430.

Charles-Schoeman C. Cardiovascular disease and rheumatoid arthritis: An update. Current Rheumatology Reports. 2012;14(5):455-462.

Sidibe A, Mannic T, Arboleas M, Subileau M, Gulino-Debrac D, Bouillet L, Jan M, Vandhuick T, le Loet X, Vittecoq O, Vilgrain I. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: Evidence for tumour necrosis factor α-induced VE-cadherin cleavage. Arthritis and Rheumatism. 2012;64(1):77-87.

Imes CC, Austin AM. Low-density lipoprotein cholesterol, apolipoprotein B and risk of coronary heart disease: From familial hyperlipidaemia to genomics. Biological Research for Nursing. 2012;15:292-308.

Edwards C. Sixty years of hench-corticosteroids and chronic inflammatory diseases. Journal of Clinical Endocrinology and Metabolism. 2012;97(50):1443-1451.

Ortega-Hernandez OD, Pineda-Tamayo R, Rojas-Villaraga A, Anaya JM. Cardiovascular disease is associated with extra-articualr manifestations in patients with rheumatoid arthritis. Clinical Rheumatology. 2009;28:767–775.

Hochberg MC, Johnson SS, John AK. The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006. Current Medical Research Opinion. 2009;24:469-480.

Nikolaisen C, Figenschau Y, Nossent JC. Anaemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. Journal of Rheumatology. 2008;35:380-386.

Demirag MD, Haznedaroglu S, Sancak B. Circulating hepcidin in the crossroads of anaemia and inflammation associated with rheumatoid arthritis. Internal Medicine. 2009;48:421-426.

Pioggiali E, Micis MMD, Motta I. Anaemia of chronic disease: A unique defect of iron recycling for many different chronic diseases. European Journal of Internal Medicine. 2014;25(1):12-17.

Siebert S, Tsoukas A, Robertson J, Mclnnes I. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases. Pharmacological Reviews. 2015;67(2):280-309.

Wadekar JB, Sawant RL, Patal UB. Rheumatoid arthritis and herbal drugs: A review. The Journal of Phytopharmacology. 2015;4(6):311-318.

Kogure T, Oku Y, Kishi D, Ito T, Tatsumi T. The influence of traditional herbal medicine (Kampo) on anti-cyclic citrullinated peptide antibody levels. Clinical Medicine: Arthritis and Mosculoskeletal Disorders. 2009;2:23-28.

Yang CLH, Or TCT, Ho MHK, Lau ASY. Scientific basis of botanical medicine as alternative remedies for rheumatoid arthritis. Clinical Reviews in Allergy & Immunology. 2013;44(3):284-300.

Curtis JR, Singh JA. The use of biologics in rheumatoid arthritis: Current and emerging paradigms of care. Clinical Therapeutics. 2011;33(6):679-707.

Paget GE, Barnes JM. Evaluation of drug activities. In Lawrence DR, Bacharach AL. (Eds.). Pharmacometrics. New York: Academy Press. 1964;161.

Organization for Economic Cooperation and Development. Guidance Document on Acute Oral Toxicity Testing; 2001.
Available:https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd-gd24.pdf
(Retrieved on 23rd November, 2018)

Foyet HS, Tsala DE, Zogo JC, Bodo JCZ, Carine AN, Heroyne LT, Oben EK. Anti-inflammatory and anti-arthritic activity of a methanol extract from Vitellaria paradoxa stem bark. Pharmacolognosy Research. 2015;7(4):367-377.

Hussein SZ, Mohd YK, Makpol S, Yusof YAM. Gelam Honey inhibits the production of proinflammatory mediators, NO, PGE2, TNF-α and IL-6 in Carrageenan-induced acute paw edema in rats. Evidence-based Complementary and Alternative Medicine; 2012.
Available:http//dx.doi.org/10.1155/109636

Vijayalaxmi A, Bakshi U, Begum N, Kowmudi V, Naveen KY, Reddy Y. Anti-arthritic and Anti-inflammatory activity of beta-caryophyllene against Freund’s complete adjuvant induced Arthritis in wister rats. Journal of Bone Reports & Recommendations. 2015;1(29):1-10.

Gabriel SE, Crowson CS. Risk factors for cardiovascular disease in rheumatoid arthritis. Current Opinions in Rheumatology. 2012;24(2):171-176.

Erum U, Ahsan T, Khowaja D. Lipid abnormalities in patients with rheumatoid arthritis. Pakistan Journal of Medical Sciences. 2017;33(1):227-230.

van Leuven SI, Franssen R, Kastekin JJ, Levi M, Stroes ESG, Tak PP. Systemic Inflammation as a Risk Factor for Atherothrombosis. Rheumatology. 2008;47(1): 3-7.

Amezaga UM, Suarez-Almazor ME. Lipid paradox in rheumatoid arthritis: Changes with rheumatoid therapy. Current Rheumatology Reports. 2012;14(1): 3-7.

Shah SAR, Baba MS, Khaliq A, Jeelani I, Shah SJ, Nadeem S. Lipid profile in rheumatoid arthritis and its relation with inflammatory markers. Insights in Biomedicine. 2017;2:1-10.

Massoleh IS, Zayeni H, Haji-Abbasi A, Azarpira M, Hadian A, Parsa, BG. Cardiac involvement in rheumatoid arthritis: A cross-sectional study in Iran. Indian Heart Journal. 2017;68(3):332-335.

Astry B, Venkatesha SH, Lawrence A, Christensen-Quick A, Garzimo-Demo A, Frieman MB, O’Shea JJ, Moudgil K. Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ. Clinical Immunology. 2015;157(2):228-238.

Curtis JR, John A, Basser O. Dyslipidaemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of Anti-TNF therapy. Arthritis Care & Research. 2012;64(9): 1282-1291.

Akramas L, Leonaviciene L, Vasiliauskas A, Bradunaite R, Vaitkiene D, Zabulyte D, Normantiene T, Lukosius, A, Jonauskiene I. Anti-inflammatory and Anti-oxidative effects of herbal preparation EM 1201 in adjuvant arthritis rats. Medicina. 2015;51:368-377.

Maroon JC, Bost JW, Maroon A. Natural anti-inflammatory agents for pain relief. Surgical Neurology International. 2010;1:80-120.

Pereira ICP, Sousa NCF, Pereira DMS, Mendes SJF, Munitz TF, Colares VLP, Silva BLR, Monteiro CRAV, Martins MMRS, Fernades AMR, Fernades ES. Treatment with either leflunomide or adalimumab reduces anaemia in patients with rheumatoid arthritis. Anais da Academia Brasileira de Ciencias. 2018;90(2 Suppl 1):2161-2166.

Goyal L, Shah PJ, Yadav RN, Saigal R, Agarwah A, Banarjee S. Anaemia in newly diagnosed patients of rheumatoid arthritis and its correlation with disease activity. Journal of the Association of Physicians of India. 2018;66:26-29.

Atabonkeng EP, Claire OAM, Singwe-Ngandeu M, Nwobegabay J, Bonsi ST, Fokou PVT, Tsague FPM, Tchakounte C, Tume C. High C-reactive protein levels, rheumatoid anaemia, Alpha-1 globulin deficiency and hypergammaglobulinaemai in rheumatoid arthritis patients from Yaounde, Cameroun. Biomedical and Biotechnology Research Journal. 2018;2:203-207.

D’Angelo G. Role of hepcidin in the pathophysiology and diagnosis of anaemia. Blood Research. 2013;48(1):10-15.

Nairz M, Schroll A, Moschen AR. Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-kappa B-Inducible immune pathways. Immunity. 2011;34:61-74.

Liu D, Zhang Y, Liu Y, Hou L, Li S, Tian H, Zhao T. Berberine modulates gut microbiota and reduces insulin resistance via the TLR4 signalling pathway. Experimental and Clinical Endocrinology and Diabetes. 2018;126(8):513-520.

Peterson CT, Sharma V, Uchitel S, Denniston K, Chopra D, Mills PJ, Peterson SN. Prebiotic potential of herbal medicines used in digestive health and disease. Journal of Alternative and Complementary Medicine. 2018;24(7):656-665.

Neeraji S, Nipum D, Jyoti M, Neeraj K. Evaluation of Anti-inflammatory and anti-arthritic activity of Ajmodadi churna - A polyherbal formulation. International Journal of Pharmaceutical and Phytopharmacological Research. 2016;6(5):72-76.

Ekambaram S, Perumah SS, Subramaniam V. Evaluation of anti-arthritic activity of Strychnos potatorum Linn. Seeds in Freund’s adjuvant-induced arthritic rat model. Complementary and Alternative Medicine. 2010;1-9.

Appusamy J, Jayaram S, Govindaraj S, Ganesan A, Kaladharan S. Evaluation of anti-inflammatory and anti-arthritic activity of Balaguluchyadi Kwatham tablets in wistar albino rat model. International Journal of Pharmacy and Pharmaceutical Research. 2018;12(3):232-339.

Shen H, Goodall JC, Hill-Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis and Rheumatology. 2009;60:1647-1656.

Fasching P, Stradner M, Graninger W, Dejaco C, Fessler J. Therapeutic potential of targeting the Th17/Treg axis in autoimmune disorders. Molecules. 2017;22:2-24.

Elechi-Amadi K, Nwachuku EO, Tamuno-emine DG, Nduka N, Briggs ON. Effect of an anti-arthritic herbal medicine on inflammatory markers in albino Wistar rats. European Journal of Biomedical and Pharmaceutical Sciences. 2019;6(10):100-103

Mahdi HJ, Khan N AK, Asmawi MZB, Mahmud R, Murugaiyah VA. In vivo anti-arthritic and antinociceptive effects of ethanol extracts of Moringa oleifera leaves on complete Freund’s adjuvant-induced arthritis in rats. Integrative Medical Research. 2018;7(1):85-94.

Bhatt L, Maithani S. Protective effect of a polyherbal formulation, Freemodex, against acute models of pain, inflammation, arthritis and immunosuppression. International Journal of Nutrition, Pharmacology and Neurological Science. 2017;7:88-93.